George Daniel Rădăvoi

Randomized Phase II Study Evaluating Akt Blockade with Ipatasertib, in Combination with Abiraterone, in Patients with Metastatic Prostate Cancer with and without PTEN Loss

Johann S. de Bono, Ugo De Giorgi, Daniel Nava Rodrigues et al. · Clinical Cancer Research · 2018 · 310 citations

Medicine, Oncology, Pharmacology +15

PTEN loss as a predictive biomarker for the Akt inhibitor ipatasertib combined with abiraterone acetate in patients with metastatic castration-resistant prostate cancer (mCRPC)

Johann S. de Bono, Ugo De Giorgi, Christophe Massard et al. · Annals of Oncology · 2016 · 53 citations · Full text

Medicine, Oncology, Pharmacology +17

Immunohistochemistry Particularities of Retroperitoneal Tumors

Ovidiu Gabriel Bratu, Radu Marcu, Bogdan Socea et al. · Revista de Chimie · 2018 · 20 citations · Full text

Medicine, Oncology, Pathology +17

Mapping European Association of Urology Guideline Practice Across Europe: An Audit of Androgen Deprivation Therapy Use Before Prostate Cancer Surgery in 6598 Cases in 187 Hospitals Across 31 European Countries

Steven MacLennan, Nuno Pereira‐Azevedo, Eilidh Duncan et al. · European Urology · 2023 · 19 citations · Full text

Medicine, Surgery, Urology +15

Can we identify the risk factors for SIRS/sepsis after percutaneous nephrolithotomy? A meta‑analysis and literature review

Dragoş Puia, Ştefan Gheorghincă, George Daniel Rădăvoi et al. · Experimental and Therapeutic Medicine · 2023 · 19 citations · Full text

Medicine, Nephrology, Surgery +16